EverlyWell

EverlyWell Overview

Founded 2015
Founded
Status Private
Employees 88
Employees
Latest Deal Type Series B
Latest Deal Amount $50M
Latest Deal Amount
Investors 11

EverlyWell General Information

Description

Developer of testing kits intended to provide access to transparent and insightful lab tests. The company develops do-it-yourself kits for a wide range of at-home regulatory-compliant diagnostic tests including food sensitivity, fertility, hormones, STDs, thyroid and metabolism among the others, enabling users to perform tests at home and receive physician-reviewed results and insights on mobile devices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 823 Congress Avenue
  • Suite 1200
  • Austin, TX 78701
  • United States
+1 (512) 000-0000

EverlyWell Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EverlyWell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 16-Apr-2019 $50M 000.00 00000 Completed Generating Revenue
4. Seed Round 28-Dec-2017 000.00 000.00 000.00 Completed Generating Revenue
3. Angel (individual) 16-Nov-2017 000 00.00 0000 Completed Generating Revenue
2. Seed Round 19-Apr-2016 $2.5M $2.5M 000.00 Completed Product In Beta Test
1. Accelerator/Incubator 01-Jan-2016 Completed Startup

EverlyWell Cap Table

To view EverlyWell‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 7,926,690 $0.000010 6% $1.29 $1.29 1x $1.29 22.01%
Seed 4,174,804 $0.000010 6% $0.75 $0.75 1x $0.75 11.59%

EverlyWell Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Cerascreen Corporation Schwerin, Germany
00000000000000 Venture Capital-Backed Dublin, Ireland 000 00000 00000000000 00000
000000 (00000 0000 Venture Capital-Backed London, United Kingdom 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
0000 & 0000 Venture Capital-Backed San Francisco, CA 000 00000 00000000000 00000

EverlyWell Executive Team (10)

Name Title Board Seat Contact Info
Julia Cheek Founder & Chief Executive Officer
Joshua Stanley Chief Financial Officer
Nick Parker Chief Technology Officer
Jenifer Dasho Chief Marketing Officer
Matthew Carroll Vice President of Marketing

5 Former Executives

EverlyWell Board Members (1)

Name Representing Role Since
Michael Smerklo Next Coast Ventures Board Member 000 0000

EverlyWell Investors (11)

To view EverlyWell‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Full Tilt Capital Venture Capital Minority 000 0000 000000 0
Goodwater Capital Venture Capital Minority 000 0000 000000 0
Highland Capital Partners Venture Capital Minority 000 0000 000000 0
Jack Novak Angel (individual) Minority 000 0000 000000 0
Next Coast Ventures Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial